Pujol-Borrell R, Hanafusa T, Chiovato L, Bottazzo G F
Nature. 1983;304(5921):71-3. doi: 10.1038/304071a0.
HLA-DR antigens, the human equivalent of mouse I region-associated or Ia products, are polymorphic cell surface sialoglycoproteins involved in initiation of the immune response. Their expression is normally restricted to B lymphocytes, macrophages, dendritic and other antigen-presenting cells and vascular endothelium and possibly some cells of the mucosa lining body cavities. HLA-DR expression can be modified during cell differentiation; B lymphocytes become negative on maturing to plasma cells and human T lymphocytes acquire these antigens when activated in vitro or in vivo. We report here that human thyroid follicular cells which are normally negative for HLA-DR molecules, can be induced to express these antigens when cultured with phytohaemagglutinin (PHA), concanavalin A (Con A) or pokeweed mitogen (PWM). These lectins exert their action directly on the thyroid cells with no concomitant mitogenic effect.
HLA - DR抗原,相当于人类的小鼠I区相关或Ia产物,是参与免疫反应起始的多态性细胞表面唾液糖蛋白。它们的表达通常局限于B淋巴细胞、巨噬细胞、树突状细胞和其他抗原呈递细胞以及血管内皮,可能还有体腔黏膜的一些细胞。HLA - DR的表达在细胞分化过程中可发生改变;B淋巴细胞成熟为浆细胞时变为阴性,而人T淋巴细胞在体外或体内被激活时会获得这些抗原。我们在此报告,通常对HLA - DR分子呈阴性的人甲状腺滤泡细胞,在用植物血凝素(PHA)、刀豆蛋白A(Con A)或商陆有丝分裂原(PWM)培养时可被诱导表达这些抗原。这些凝集素直接作用于甲状腺细胞,无伴随的促有丝分裂效应。